ANI Pharmaceuticals Inc
NASDAQ:ANIP
ANI Pharmaceuticals Inc
NASDAQ:ANIP
Price:
61.73 USD
0.49%
Market Closed
Updated:
May 21, 2024
ANI Pharmaceuticals Inc
Total Other Income
|
ANI Pharmaceuticals Inc
Total Other Income Peer Comparison
Comparables:
JNJ
BMY
PFE
MRK
LLY
Competitive Total Other Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Total Other Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ANI Pharmaceuticals Inc
NASDAQ:ANIP
|
Total Other Income
-$165k
|
CAGR 3-Years
45%
|
CAGR 5-Years
23%
|
CAGR 10-Years
6%
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Total Other Income
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Total Other Income
-$149m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-54%
|
|
|
Pfizer Inc
NYSE:PFE
|
Total Other Income
-$5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
50%
|
CAGR 10-Years
N/A
|
|
|
Merck & Co Inc
NYSE:MRK
|
Total Other Income
$1.5B
|
CAGR 3-Years
48%
|
CAGR 5-Years
41%
|
CAGR 10-Years
18%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Total Other Income
$456.1m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
3%
|
CAGR 10-Years
20%
|
See Also
What is ANI Pharmaceuticals Inc's Total Other Income?
Total Other Income
-165k
USD
-165k
USD
Based on the financial report for Mar 31, 2024, ANI Pharmaceuticals Inc's Total Other Income amounts to -165k USD.
What is ANI Pharmaceuticals Inc's Total Other Income growth rate?
Total Other Income CAGR 10Y
6%
6%
The average annual Total Other Income growth rates for ANI Pharmaceuticals Inc have been 45% over the past three years , 23% over the past five years , and 6% over the past ten years .
You don't have any saved screeners yet
